For research use only. Not for therapeutic Use.
Heat shock protein (Hsp) inhibitor II is the active form of Hsp inhibitor I (Item No. <span class=/itemid/>15395</span>) and a benzylidene lactam compound that prevents the synthesis of inducible Hsps, such as Hsp105, Hsp72, and Hsp40. Hsp inhibitor II decreases Hsp72 synthesis <em>in vivo</em> and reduces thermotolerance of tumors in SCC VII tumor-containing mice. At 100 µM, it inhibits the development of thermotolerance in COLO 320 DM cells. Inhibition of Hsp70 with Hsp inhibitor II in combination with amphotericin B (AmB; Item No. <span class=/itemid/>11636</span>) increases susceptibility of AmB-susceptible (MICs = 0.058 <em>versus</em> 0.27 µg/ml for combined and AmB alone, respectively) and AmB-resistant (MICs = 21.33 <em>versus</em> >32 µg/ml for combined and AmB alone, respectively) strains of <em>A. fumigatus</em>.
Catalog Number | R067119 |
CAS Number | 1859-42-3 |
Synonyms | Hsp Inhibitor II;KNK 423 |
Molecular Formula | C12H11NO3 |
Purity | ≥95% |
Target | Metabolic Enzyme/Protease |
Storage | -20°C |
IUPAC Name | 3-(1,3-benzodioxol-5-ylmethylidene)pyrrolidin-2-one |
InChI | InChI=1S/C12H11NO3/c14-12-9(3-4-13-12)5-8-1-2-10-11(6-8)16-7-15-10/h1-2,5-6H,3-4,7H2,(H,13,14) |
InChIKey | IJPPHWXYOJXQMV-UHFFFAOYSA-N |
SMILES | C1CNC(=O)C1=CC2=CC3=C(C=C2)OCO3 |
Reference | 1.Koishi, M.,Yokota, S.,Mae, T., et al. The effects of KNK437, a novel inhibitor of heat shock protein synthesis, on the acquisition of thermotolerance in a murine transplantable tumor in vivo. Clin. Cancer Res. 7(1), 215-219 (2001). |